+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Methimazole"

Anti-Thyroid Drugs Market Report 2025 - Product Thumbnail Image

Anti-Thyroid Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Graves' Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
From
Goiter Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Goiter Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Methimazole is a drug used to treat endocrine and metabolic disorders, such as hyperthyroidism. It works by blocking the production of thyroid hormones, which helps to reduce the symptoms of the disorder. It is available in both oral and topical forms, and is usually taken once or twice a day. Side effects of the drug include rash, nausea, and headache. Methimazole is a widely used drug in the endocrine and metabolic disorder market. It is used to treat a variety of conditions, including Graves' disease, toxic nodular goiter, and thyroid cancer. It is also used to treat hyperthyroidism in pregnant women. The market for Methimazole is highly competitive, with many companies offering the drug. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more